南美洲冻干注射剂市场预测至 2028 年 - COVID-19 影响和按包装类型(一次性小瓶、护理点重构和特种包装)、交付类型(预装稀释剂注射器、单步装置)进行的区域分析、专有重构设备和多步骤设备)、适应症(代谢和肿瘤疾病、传染病、自身免疫性疾病等)和最终用户(医院、门诊手术中心、专科诊所等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 117    |    Report Code: BMIRE00027600    |    Category: Life Sciences

South America Lyophilized Injectable Market

SAM冻干注射剂市场预计将从2022年的1.3884亿美元增长到2028年的1.8145亿美元。预计2022年至2028年复合年增长率为4.6%。    

冻干注射药物产品线扩张

持续开发治疗慢性病药物的研究推动了制药行业冻干注射药物的发展。关键参与者的产品创新和战略活动提供了渗透新治疗领域/市场的机会。大约有 2,400 种注射产品正在开发中。药物开发商对冻干技术越来越感兴趣,因为它可以延长小分子和大分子药物的保质期。复杂原料药和生物制剂制剂稳定性挑战的普遍存在导致更多的制药和生物制药制造商转向冻干。过去 5 年,冻干技术在药品和生物制药产品制造中的使用每年增长约 13.5%。由于液体是许多肠胃外产品商业规模生产的首选配方,因此冻干对于将液体产品推向市场越来越重要。冻干之所以重要,有两个原因,即增加新药申请数量和减少新药批准的审查时间。在肠外给药占主导地位的治疗领域,有超过 3,000 种候选药物正在研发中。在这 3,000 种产品中,约 2,250 种处于临床前开发/第一阶段。其余候选产品,约 750 种处于第二阶段和第三阶段。而该冻干产品管线在未来一段时间内只会增加到既定的冻干药物清单中。因此,预计将扩大冻干注射剂市场。

市场概述

SAM 冻干注射剂市场分为巴西、阿根廷和 SAM 的其他地区。 2022年,巴西占据市场主导地位。巴西70%的医药业务依赖医药产品进口。例如,2019年进口药品70亿美元,其中生物药品20亿美元,占进口总额的30%。然而,COVID-19 大流行为巴西和世界各国的国内药品生产提供了重要的增长机会。巴西仿制药工业协会 (PróGenlicos) 和 FarmaBrasil Group (GFB) 等巴西协会表示,该国的生产能力占该国药品总需求量的近 75%。因此,预计国内冻干注射剂的需求将会增加。此外,2019年,该国进口了大量生物制品或免疫治疗药物,价值10亿美元。因此,预计将投入巨额资金进口医药产品。国家可以投资国内药品生产,仅进口冻干注射剂。此外,与 FarmaBrasil 集团有关联的在该国运营的公司承诺通过生产发展伙伴关系 (PDP) 在国内生产药品,包括贝伐单抗、帕利珠单抗、英夫利昔单抗、β-干扰素 1A 和胰岛素。因此,这种国内生产的战略举措将增加对冻干注射剂的需求,并最终导致未来几年的市场增长。

SAM 冻干注射剂市场收入和到 2028 年的预测(百万美元)

  

SAM 冻干注射剂市场细分     

SAM 冻干注射剂市场根据类型进行细分包装、交付类型、适应症、最终用户和国家/地区。

根据包装类型,SAM 冻干注射剂市场分为一次性小瓶、点用- 护理重组和专业包装。 2022 年,一次性小瓶细分市场占据最大市场份额。

就输送类型而言,SAM 冻干注射剂市场细分为预充式稀释剂注射器、单步注射器设备、专有重构设备和多步骤设备。预充式稀释注射器细分市场在 2022 年占据最大市场份额。

根据适应症,SAM 冻干注射剂市场分为代谢和肿瘤疾病、传染病、自身免疫性疾病、和别的。代谢和肿瘤疾病领域在 2022 年占据最大的市场份额。

根据最终用户,SAM 冻干注射剂市场分为医院、门诊手术中心、专科诊所、和别的。 2022 年,医院细分市场占据最大的市场份额。

按国家/地区划分,SAM 冻干注射剂市场分为巴西、阿根廷和 SAM 的其他地区。巴西将在 2022 年占据市场主导地位。  

Aristopharma 有限公司;巴克斯特;克莱登斯医疗系统公司; Jubilant HollisterStier(Jubilant Pharma Limited);尼普罗; Recipharm AB; SG 生物制药有限公司有限公司;和 Vetter Pharma 是 SAM 冻干注射剂市场的领先公司之一。      



South America Lyophilized Injectable Strategic Insights

Strategic insights for South America Lyophilized Injectable involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-americalyophilized-injectable-market-strategic-framework.webp
Get more information on this report

South America Lyophilized Injectable Report Scope

Report Attribute Details
Market size in 2022 US$ 138.84 Million
Market Size by 2028 US$ 181.45 Million
Global CAGR (2022 - 2028) 4.6%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 包装类型
  • 一次性小瓶
  • 即时复溶
  • 特殊包装
By 输送类型
  • 预充式稀释剂注射器
  • 单步装置
  • 专有重构装置
  • 多步装置
By 适应症
  • 代谢和肿瘤疾病
  • 传染病
  • 自身免疫性疾病
By 最终用户
  • 医院
  • 门诊手术中心
  • 专科诊所
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Aristopharma Ltd.
  • Baxter
  • Credence MedSystems, Inc.
  • Jubilant HollisterStier (Jubilant Pharma Limited)
  • Nipro
  • Recipharm AB
  • S.G. Biopharm Pvt. Ltd.
  • Vetter Pharma
  • Get more information on this report

    South America Lyophilized Injectable Regional Insights

    The regional scope of South America Lyophilized Injectable refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-americalyophilized-injectable-market-geography.webp
    Get more information on this report

    The List of Companies - South America Lyophilized Injectable Market

    1. Aristopharma Ltd.
    2. Baxter
    3. Credence MedSystems, Inc.  
    4. Jubilant HollisterStier (Jubilant Pharma Limited)
    5. Nipro
    6. Recipharm AB
    7. S.G. Biopharm Pvt. Ltd.    
    8. Vetter Pharma       
    Frequently Asked Questions
    How big is the South America Lyophilized Injectable Market?

    The South America Lyophilized Injectable Market is valued at US$ 138.84 Million in 2022, it is projected to reach US$ 181.45 Million by 2028.

    What is the CAGR for South America Lyophilized Injectable Market by (2022 - 2028)?

    As per our report South America Lyophilized Injectable Market, the market size is valued at US$ 138.84 Million in 2022, projecting it to reach US$ 181.45 Million by 2028. This translates to a CAGR of approximately 4.6% during the forecast period.

    What segments are covered in this report?

    The South America Lyophilized Injectable Market report typically cover these key segments-

  • 包装类型 (一次性小瓶, 即时复溶, 特殊包装)
  • 输送类型 (预充式稀释剂注射器, 单步装置, 专有重构装置, 多步装置)
  • 适应症 (代谢和肿瘤疾病, 传染病, 自身免疫性疾病)
  • What is the historic period, base year, and forecast period taken for South America Lyophilized Injectable Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Lyophilized Injectable Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America Lyophilized Injectable Market?

    The South America Lyophilized Injectable Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Aristopharma Ltd.
  • Baxter
  • Credence MedSystems, Inc.
  • Jubilant HollisterStier (Jubilant Pharma Limited)
  • Nipro
  • Recipharm AB
  • S.G. Biopharm Pvt. Ltd.
  • Vetter Pharma
  • Who should buy this report?

    The South America Lyophilized Injectable Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Lyophilized Injectable Market value chain can benefit from the information contained in a comprehensive market report.